BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis
Europe - EPA:ALTUV - FR0013345493 - Common Stock
1.64 EUR
+0 (+0.12%)
ALTUV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 107 industry peers in the Machinery industry. Both the profitability and the financial health of ALTUV get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, ALTUV is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ALTUV had positive earnings in the past year.
ALTUV had a positive operating cash flow in the past year.
In the past 5 years ALTUV has always been profitable.
Of the past 5 years ALTUV 4 years had a positive operating cash flow.
1.2 Ratios
ALTUV has a Return On Assets of 1.36%. This is comparable to the rest of the industry: ALTUV outperforms 41.12% of its industry peers.
Looking at the Return On Equity, with a value of 2.41%, ALTUV is doing worse than 62.62% of the companies in the same industry.
The Return On Invested Capital of ALTUV (2.84%) is worse than 68.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALTUV is below the industry average of 8.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROIC | 2.84% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
1.3 Margins
ALTUV has a Profit Margin (2.64%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ALTUV has declined.
ALTUV's Operating Margin of 5.93% is in line compared to the rest of the industry. ALTUV outperforms 50.47% of its industry peers.
In the last couple of years the Operating Margin of ALTUV has grown nicely.
ALTUV has a Gross Margin (38.14%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALTUV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% |
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALTUV is destroying value.
ALTUV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALTUV has more shares outstanding
The debt/assets ratio for ALTUV has been reduced compared to a year ago.
2.2 Solvency
ALTUV has an Altman-Z score of 1.46. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.46, ALTUV is not doing good in the industry: 63.55% of the companies in the same industry are doing better.
ALTUV has a debt to FCF ratio of 7.69. This is a slightly negative value and a sign of low solvency as ALTUV would need 7.69 years to pay back of all of its debts.
ALTUV has a Debt to FCF ratio of 7.69. This is comparable to the rest of the industry: ALTUV outperforms 44.86% of its industry peers.
ALTUV has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
ALTUV has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: ALTUV outperforms 46.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Altman-Z | 1.46 |
ROIC/WACC0.41
WACC7%
2.3 Liquidity
ALTUV has a Current Ratio of 2.05. This indicates that ALTUV is financially healthy and has no problem in meeting its short term obligations.
ALTUV has a Current ratio of 2.05. This is in the better half of the industry: ALTUV outperforms 79.44% of its industry peers.
A Quick Ratio of 1.31 indicates that ALTUV should not have too much problems paying its short term obligations.
ALTUV has a better Quick ratio (1.31) than 78.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 195.24% over the past year.
ALTUV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.42% yearly.
ALTUV shows a decrease in Revenue. In the last year, the revenue decreased by -7.99%.
Measured over the past years, ALTUV shows a quite strong growth in Revenue. The Revenue has been growing by 14.65% on average per year.
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
3.2 Future
ALTUV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.51% yearly.
ALTUV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.57% yearly.
EPS Next Y-49.94%
EPS Next 2Y-5.08%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 23.43 indicates a rather expensive valuation of ALTUV.
The rest of the industry has a similar Price/Earnings ratio as ALTUV.
ALTUV is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.67, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.69, ALTUV is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ALTUV is valued a bit more expensive than the industry average as 60.75% of the companies are valued more cheaply.
ALTUV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 31.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.43 | ||
| Fwd PE | 17.69 |
4.2 Price Multiples
ALTUV's Enterprise Value to EBITDA ratio is in line with the industry average.
80.37% of the companies in the same industry are more expensive than ALTUV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.45 | ||
| EV/EBITDA | 9.25 |
4.3 Compensation for Growth
ALTUV's earnings are expected to grow with 14.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.08%
EPS Next 3Y14.51%
5. Dividend
5.1 Amount
ALTUV has a Yearly Dividend Yield of 2.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.62, ALTUV pays a bit more dividend than its industry peers.
ALTUV's Dividend Yield is comparable with the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-5.08%
EPS Next 3Y14.51%
EPA:ALTUV (11/6/2025, 7:00:00 PM)
1.64
+0 (+0.12%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners6.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.21M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target3.06 (86.59%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-74.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.43 | ||
| Fwd PE | 17.69 | ||
| P/S | 0.61 | ||
| P/FCF | 8.45 | ||
| P/OCF | 4.87 | ||
| P/B | 0.56 | ||
| P/tB | 4.53 | ||
| EV/EBITDA | 9.25 |
EPS(TTM)0.07
EY4.27%
EPS(NY)0.09
Fwd EY5.65%
FCF(TTM)0.19
FCFY11.83%
OCF(TTM)0.34
OCFY20.55%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROCE | 3.87% | ||
| ROIC | 2.84% | ||
| ROICexc | 2.84% | ||
| ROICexgc | 7.55% | ||
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% | ||
| FCFM | 7.26% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Debt/EBITDA | 3.38 | ||
| Cap/Depr | 79.6% | ||
| Cap/Sales | 5.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.7% | ||
| Profit Quality | 275.52% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 1.46 |
F-Score7
WACC7%
ROIC/WACC0.41
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-49.94%
EPS Next 2Y-5.08%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A
BIO-UV GROUP SAS / ALTUV.PA FAQ
Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?
ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.
What is the valuation status for ALTUV stock?
ChartMill assigns a valuation rating of 3 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Overvalued.
What is the profitability of ALTUV stock?
BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.
How financially healthy is BIO-UV GROUP SAS?
The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.
What is the earnings growth outlook for BIO-UV GROUP SAS?
The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -49.94% in the next year.